Loading...
EBR Systems, Inc.
EBRCZ•PNK
Healthcare
Medical - Specialties
$0.55
$0.00(0.00%)
EBR Systems, Inc. (EBRCZ) Financial Performance & Statements
Review EBR Systems, Inc.’s income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns to understand its financial health and growth.
Revenue Growth
0.00%
Operating Income Growth
44.94%
↑ 44.94%
Net Income Growth
42.42%
↑ 42.42%
Operating Cash Flow Growth
-26.09%
↓ 26.09%
Operating Margin
0.00%
Gross Margin
0.00%
Net Profit Margin
0.00%
ROE
-289.20%
↓ 289.20%
ROIC
-14.25%
↓ 14.25%
EBR Systems, Inc. (EBRCZ) Financial Statements
Explore quarterly and annual reports including balance sheet, income statement, cash flow for EBR Systems, Inc. stock.
| Metric | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 |
|---|---|---|---|---|
| Revenue | $0.00 | $0.00 | $0.00 | $0.00 |
| Cost of Revenue | $0.00 | $0.00 | $0.00 | $0.00 |
| Gross Profit | $0.00 | $0.00 | $0.00 | $0.00 |
| Gross Profit Ratio | $0.00 | $0.00 | $0.00 | $0.00 |
| R&D Expenses | $6.89M | $6.30M | $7472.00 | $6401.00 |
| SG&A Expenses | $2.93M | $2.88M | $3270.00 | $2173.00 |
| Operating Expenses | $9.83M | $9.18M | $10741.00 | $8574.00 |
| Total Costs & Expenses | $9.83M | $9.18M | $10741.00 | $8574.00 |
| Interest Income | $830746.00 | $651314.00 | $0.00 | $0.00 |
| Interest Expense | $1.47M | $1.53M | $0.00 | $0.00 |
| Depreciation & Amortization | $192407.00 | $646814.00 | $182.00 | $213.00 |
| EBITDA | -$8.43M | -$8.53M | -$10559.00 | -$8361.00 |
| EBITDA Ratio | ||||
| Operating Income | -$9.83M | -$9.18M | -$10742.00 | -$8574.00 |
| Operating Income Ratio | ||||
| Other Income/Expenses (Net) | -$270405.00 | -$878932.00 | -$753.00 | -$576.00 |
| Income Before Tax | -$10.10M | -$10.06M | -$11495.00 | -$9150.00 |
| Income Before Tax Ratio | ||||
| Income Tax Expense | $1535.00 | $0.00 | $0.00 | $0.00 |
| Net Income | -$10.10M | -$10.06M | -$11495.00 | -$9150.00 |
| Net Income Ratio | ||||
| EPS | -$0.03 | -$0.03 | $0.00 | $0.00 |
| Diluted EPS | -$0.03 | -$0.03 | $0.00 | $0.00 |
| Weighted Avg Shares Outstanding | $311.19M | $311.19M | $308.10M | $307.43M |
| Weighted Avg Shares Outstanding (Diluted) | $311.19M | $311.19M | $308.10M | $307.42M |
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan